Promising clinical performance of 89Zirconium-labelled Girentuximab PET-CT for imaging metastatic triple negative breast cancer patients (OPALESCENCE)

Caroline Rousseau, Marie Francoise Heymann,Jean Sebastien Frenel, Elise Picot-Dilly,Maelle Le Thiec, Manon Taupin, Alexis Mouton,Emmanuelle Bourbouloux,Agnes Morel,Nadia Allam, Amelie Mallet, Mario Campone,Ludovic Ferrer, Francoise Kraeber-Bodere

CANCER RESEARCH（2024）

Cited 0|Views0

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined